Loading...
Images of Angela Zubel
(0 from 0 )1
0
0
News
AUTOMA+ Networking Leaderboard - Healthcare ...
automahealth.com
176, Angela ZubelErica BonnsFernanda ZaganelliKariem El-KholyNuray YurtRevita Zanin, 1. › blog › news
Debiopharm Advances its Potent Wee1 Inhibitor into Clinical ...
www.almacgroup.com
Mar 5, — ... such as chemo- and radiation-therapies” explained Angela Zubel, Chief Development Officer, Research & Development, Debiopharm. › News Items
Debiopharm begins enrolment in CATRIPCA trial
www.clinicaltrialsarena.com
Oct 10, — Debiopharm chief development officer Dr Angela Zubel said: “This study is the third of a series of immuno-oncology studies investigating the ... › news › debiophar...
Debiopharm's experimental drug gets US FDA Breakthrough ...
futuremedicineindia.com
Mar 5, — ... high-risk locally-advanced head and neck cancer remains an area of unmet medical need,” said Angela Zubel, chief development officer, ... › news › debiopharms-...
Telephone & Addresses
Last Name: Zubel (Page 1) - Advanced Background Checks
www.advancedbackgroundchecks.com
Alison Zubel · Amanda Zubel · Ambrose Zubel · An Zubel · Andrew Zubel · Andy Zubel · Angela Zubel · Anna Zubel · Anne Zubel · Annie Zubel · Anthony Zubel ...
Angela Zubel im Das Telefonbuch >> Jetzt finden!
www.dastelefonbuch.de
Angela Zubel mit ✉ Adresse ☎ Tel. und mehr bei ☎ Das Telefonbuch ✓ Ihre Nr. 1 für Adressen und Telefonnummern
Physicians & MDs
a double-blind, multicentre, randomised, phase 2 study - The ...
www.thelancet.com
... MD, Valentin Calugaru, MD, Lionnel Geoffrois, MD, Bruno Chauffert, MD, Angela Zubel, MD, Claudio Zanna, MD, Silvano Brienza, MD, Philippa Crompton, MSc, MD, J Thaddeus Beck, MD, Annie St-Pierre, PhD, Faiz Niazi, MPharm, Simon Wandel, PhD, Malte Peters, MD, Angela Zubel, MD, Prof Reinhard Dummer, MD. › lanonc › article › ppt
FDA Grants Breakthrough Therapy Designation for Debiopharm's Novel...
www.medindia.net
... innovative radio-chemo enhancing treatment for LA-SCCHN patients," commented Angela Zubel, Chief Development Officer, Debiopharm.
Network Profiles
LinkedIn: Angela Zubel – Chief Development Officer – Debiopharm ...ch.linkedin.com › angela-zubel
Sehen Sie sich das Profil von Angela Zubel im größten Business-Netzwerk der Welt an. Im Profil von Angela Zubel sind 4 Jobs angegeben. Auf LinkedIn können ...
Andreas Kriegler, Head of Market at Schleuniger Group
data-lead.com
Feb 24, — ... are Uwe Kriegshäuser, Markus Mateescu, Angela Zubel, Steffen Krimmer, Siegfried Krimmer, Moritz Krien, Martin Kriener, Michael Küfner. › person › name › Andreas+Krieg...
Interests
Debiopharm Expands Its Immuno-oncology Development ...
markets.businessinsider.com
May 21, — Angela Zubel, Chief Development Officer, Debiopharm International SA. About Debio Debio is a IAPs inhibitor with a dual mode of ... › news › stocks › de...
Bibliografia UJ CM
expertus.bm.cm-uj.krakow.pl
... Juliana Pereira, Luiza Akria, Sergey Alexeev, Eugeniy Osmanov, Peijuan Zhu, Siyka Alexandrova, Angela Zubel, Olof Harlin, Jutta Amersdorffer. › ...
Debio and high-dose cisplatin chemoradiotherapy in ...
www.em-consulte.com
... MD, Valentin Calugaru, MD, Lionnel Geoffrois, MD, Bruno Chauffert, MD, Angela Zubel, MD, Claudio Zanna, MD, Silvano Brienza, MD, Philippa Crompton, MSc, ... › article
FDA Grants Breakthrough Therapy Designation for ...markets.businessinsider.com › news › stocks › fda-gran...
markets.businessinsider.com
... innovative radio-chemo enhancing treatment for LA-SCCHN patients," commented Angela Zubel, Chief Development Officer, Debiopharm.
Private Homepages
Caris Life Sciences Partners with Debiopharm International ...
www.carislifesciences.com
“This collaboration represents a key milestone in the advancement of a new tumor-agnostic approach,” explained Angela Zubel, Chief Development Officer at ... › news-and-media › c...
Books & Literature
Full Text Journal Articles by Author Ernst U Steinhauer (Page 1)
pdf.manuscriptpro.com
... Christophe Borg, Gary Middleton, Hendrik Kröning, Gabriele Luppi, Oliver Kisker, Angela Zubel, Christiane Langer, Justin Kopit, Howard A Burris,. › search › Author-Ernst-...
Estrogen Receptor Alpha and ADAM9 Expression in CIN Lesions and...
books.google.de
Angela Zubel pages. 0 Reviewshttp://books.google.com/books/about/ Estrogen_Receptor_Alpha_and_ADAM9_Expres.html?id=01TNYgEACAAJ ...
Related Documents
A phase lb, open-label, multicenter, dose Meeting Library
meetinglibrary.asco.org
... Jose Manuel Perez-Garcia, Angela Zubel, Ngocdiep T. Le, Kirsten Carter, Kevin M. Bellew, Chiara Gallarati, Faiz Niazi, David Demanse, Stefan S. De Buck, ... › record › abstract
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As ...
www.albertovannelli.it
by E Van Cutsem · · Cited by — Igor Shchepotin, Joan Maurel, David Cunningham, Sabine Tejpar, Michael Schlichting, Angela Zubel,. Ilhan Celik, Philippe Rougier, and Fortunato Ciardiello. › articles › CRYSTAL
Debiopharm To Present Late Breaking PR Newswire UK
www.prnewswire.co.uk
Sep 17, — ... could significantly extend the lives of these high risk patients," expressed Angela Zubel - Chief Development Officer, R&D, Debiopharm. › news-releases › debiop...
Efficacy and safety of oral MEK162 in patients with locally ...
pdfs.semanticscholar.org
by PA Ascierto · Cited by 88 — Christian U. Blank, Axel Hauschild, J. Thaddeaus Beck,. Angela Zubel, Faiz Niazi, Simon Wandel, Reinhard Dummer. *National Cancer Institute, Naples. › ...
Scientific Publications
Randomized phase II study of the anti-epidermal growth factor ...
pubmed.ncbi.nlm.nih.gov
by J Baselga · · Cited by 380 — ... Marie-Pascale Graas, M John Kennedy, Eva Maria Ciruelos Gil, Andreas Schneeweiss, Angela Zubel, Jutta Groos, Helena Melezínková, Ahmad Awada ... › ...
Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of...
www.sciencedirect.com
Angela Zubel a, Christa Flechtenmacher b, Lutz Edler a, Angel Alonso aa Deutsches Krebsforschungszentrum, Im Neuenheimer Feld-242, Heidelberg, Germany;
A phase Ib dose-escalation study of the oral pan-PI3K inhibitor...
pubmed.ncbi.nlm.nih.gov
At RP2D, buparlisib 60 mg + trametinib 1.5 mg daily shows promising antitumor activity for patients with KRAS-mutant ovarian cancer. Long-term tolerability of...
Publications
MEK162 for patients with advanced melanoma harbouring NRAS or Val
core.ac.uk
... Christian U Blank, Axel Hauschild, J Thaddeus Beck, Annie St-Pierre, Faiz Niazi, Simon Wandel, Malte Peters, Angela Zubel and Reinhard Dummer ...
▷ Debiopharm advances into the highly anticipated clinical phase for...
www.presseportal.de
... with DNA damaging treatments, such as chemo- and radiation-therapies" explained Angela Zubel, Chief Development Officer, Debiopharm.
Efficacy and safety of oral MEK162 in patients with locally ...
www.optimer.org
Angela Zubel, Faiz Niazi, Simon Wandel, Reinhard Dummer *National Cancer Institute, Naples Italy. Disclosures
Miscellaneous
Randomized Phase III Trial of Cetuximab Plus Irinotecan vs ...
slideplayer.com
... Yousif Abubakr 7, Angela Zubel 8, Christiane Langer 9, Howard Burris III Ospedale San Martino, Genova, Italy; 2 Kaiser Permanente Medical Center, ... › slide
Angela Zubel's email & phone | Merck Group's Medical Director email
rocketreach.co
› angela-zubel-email_
Angela Zubel | LinkedIn
www.linkedin.com
View Angela Zubel’s professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Angela Zubel discover inside ...
| Sigma-Aldrich
www.sigmaaldrich.com
Angela Zubel et al. Gynecologic oncology, 114(2), ( ). ADAM9 is a member of the ADAM family which is involved in cellular processes like ... Results of 469 — Angela Zubel et al. Gynecologic oncology, 114(2), ( ). ADAM9 is a member of the ADAM family which is involved in ... › search
A Phase Ib dose-escalation study of the oral pan-PI3K ...
portalrecerca.uab.cat
by PL Bedard · · Cited by 243 — ... Ngocdiep Le, Kirsten Carter, David Demanse, Denes Csonka, Malte Peters, Angela Zubel, Heidi Nauwelaerts, Cristiana Sessa. › publications
Caris Life Sciences Inks CDx Collaboration With Debiopharm
www.genomeweb.com
May 30, — ... milestone in the advancement of a new tumor-agnostic approach," Debiopharm Chief Development Officer Angela Zubel said in a statement. › ... › Business News
Caris Life Sciences Partners with Debiopharm International ...
www.asianhhm.com
May 31, — "This collaboration represents a key milestone in the advancement of a new tumor-agnostic approach," explained Angela Zubel, ... › pressreleases › caris-life-sc...
Caris Life Sciences and Debiopharm Collaborate in the ...
www.oncozine.com
May 30, — This collaboration represents a key milestone in the advancement of a new tumor-agnostic approach,? said Angela Zubel, Chief Development ... › caris-life-sciences-and-deb...
Debiopharm Company Contact Information - Adapt.io
www.adapt.io
Angela Zubel. Chief Development Officer. +4******11. Thierry Mauvernay. President and Delegate of the Board, Debiopharm Group. › debiopharm-international-sa-1
Debiopharm Company Profile - Office Locations, Competitors ...
craft.co
Angela Zubel. Chief Development Officer, Debiopharm International S.A.. Show all. Debiopharm Office Locations. Debiopharm has offices in Lausanne and Oss. › debiopharm
Debiopharm renforce sa présence en immuno-oncologie par ...
www.caducee.net
May 21, — Angela Zubel, Chief Development Officer, Debiopharm International SA. A propos Debio Debio est un inhibiteur d'IAP qui agit sur ... › debiophar...
Debiopharm's IAP Antagonist Significantly Improves Overall ...
pipelinereview.com
Aug 13, — ... therapy could change the way these patients are treated from the start," stated Angela Zubel, Chief Development Officer, Debiopharm. › Small-Molecules › Debiop...
EPIC: phase III trial of cetuximab plus irinotecan HAL-Inria
hal.inria.fr
... Heinz-Josef Lenz Christophe Borg 1 Gary Middleton Hendrik Kröning Gabriele Luppi Oliver Kisker Angela Zubel Christiane Langer Justin Kopit Howard Burris › inserm
Expression of ADAM9 in CIN3 lesions and squamous cell ...
www.gynecologiconcology-online.net
by A Zubel · · Cited by 39 — Angela Zubel a, Christa Flechtenmacher b, Lutz Edler a, Angel Alonso a,⁎ a Deutsches Krebsforschungszentrum, Im Neuenheimer Feld-242, ... › article › pdf
FDA Grants Breakthrough Therapy Designation for ...
www.pharmalive.com
by D Haughton — ... an innovative radio-chemo enhancing treatment for LA-SCCHN patients,” commented Angela Zubel, Chief Development Officer, Debiopharm. › fda-grants-breakthrough...
Fluorouracil, Leucovorin, and Oxaliplatin With and Without ...
www.sitetv.net
Apr 8, — Conception and design: Carsten Bokemeyer, Angela Zubel ... Gunter Schuch, Christopher Stroh, Anja H. Loos, Angela Zubel, Piotr Koralewski ... › fluorouracil-leucovorin-and-ox...
Related search requests for Angela Zubel
| Malte Peters Ilhan Celik Michael Schlichting | Philippe Rougier Joan Maurel Simon Wandel | Piotr Koralewski Claudio Zanna Philippa Crompton |
People Forename "Angela" (58329) Name "Zubel" (51) |
sorted by relevance / date